Covaxin gets emergency use approval for kids
Hyderabad-based pharma major Bharat Biotech's Covaxin got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India. The Subject Expert Committee on Covid-19 gave the approval for the emergency use in the children.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Children | COVID-19 | Emergency Medicine | India Health | Pharmaceuticals